Abiopharma

🔍 DE ANGOITIA ALFONSO (Director)

Company: Liberty Latin America Ltd. (LILA)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 976 shares of Class A Common Shares at $8.64 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,162.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,953 shares of Class C Common Shares at $8.82 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 101,800.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Acquired in accordance with the terms of the Liberty Latin America 2018 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of common shares on March 31, 2026.
• REMARKS: The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK.